Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serine protease 52, pseudogene (PRSS52P) is a predicted, noncoding pseudogene in the human genome. It is a homolog of serine protease family genes but does not code for a functional enzyme, protein, or receptor. The gene structure suggests similarity to active serine proteases, but sequence characteristics and lack of expression or function confirm it is not a protein-coding gene. As a pseudogene, it does not serve as a therapeutic target, is not involved in known signaling pathways, and has no documented association with drugs, disease, or biomarker use in clinical or research contexts.
Not applicable; no protein produced
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serine protease 52, pseudogene (PRSS52P).